What is cardiac calcium imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Cardiac Calcium Imaging

Cardiac calcium imaging, also known as coronary artery calcium (CAC) scoring, is a non-invasive CT scan that detects and quantifies calcium deposits in the coronary arteries as a marker of atherosclerotic disease burden. 1, 2

Technical Overview

  • CAC imaging uses either electron beam tomography (EBT) or multidetector CT (MDCT) to detect coronary calcification without contrast administration. 1

  • The scan is performed using ECG-gated multidetector computed tomography with relatively low radiation exposure (0.9-1.5 mSv), comparable to 1-2 mammograms. 2, 3

  • The Agatston score is the most widely used scoring system, defining calcific lesions as having CT density >130 Hounsfield units and area >1 mm². 3, 4

  • Alternative scoring methods include Volume score and Mass score, though the Agatston score remains the most extensively studied and widely accepted technique in both clinical and research settings. 4

What CAC Imaging Measures

  • Calcification does not occur in a normal vessel wall, thus signifying the presence of atherosclerosis; however, it is not specific for luminal obstruction. 1

  • CAC scores approximate the total atherosclerotic plaque burden, with the degree of coronary calcification correlated with the extent of total atherosclerotic burden. 1, 3

  • Coronary calcifications are exclusively present in atherosclerotic lesions of the intimal layer, representing definitive evidence of atherosclerosis. 3, 5

  • Cardiovascular risk increases proportionally to the calcium score, with adjusted relative risks escalating at thresholds of 11-100,101-400,401-1,000, and >1,000. 3, 5

Clinical Applications and Appropriate Use

Primary Indications

  • CAC scoring is most appropriate for asymptomatic adults aged 40-75 years at intermediate risk (7.5-20% 10-year ASCVD risk) or borderline risk (5-7.5% 10-year ASCVD risk) when decisions about preventive interventions, particularly statin therapy, remain uncertain. 2, 3

  • The American Heart Association gives CAC scoring a Class IIa recommendation (Level of Evidence: B-NR) for these intermediate-risk patients to guide shared decision-making. 2

  • Selected low-risk adults with family history of premature coronary heart disease may be considered for CAC scoring. 2, 3

Risk Stratification Value

  • A calcium score of zero indicates excellent prognosis with very low risk (<1% annually) for cardiac death or myocardial infarction. 3, 5

  • Among 220 symptomatic women with normal coronary arteriograms, none had detectable CAC, yielding a negative predictive value of 100%. 1

  • For women, risk-adjusted relative risk ratios for all-cause mortality were elevated 2.5-, 3.7-, 6.3-, and 12.3-fold for calcium scores of 11 to 100,101 to 400,401 to 1000, and >1000, respectively. 1

  • CAC scoring provides incremental prognostic value beyond traditional risk factors, particularly in the intermediate-risk population where reclassification of risk can significantly impact treatment decisions. 2, 6

Important Limitations and Caveats

  • CAC testing is not appropriate as a surrogate for angiographic disease detection because of the modest relationship between CAC and obstructive coronary artery disease. 1

  • Calcium testing was not recommended in the 2000 ACC/AHA expert consensus document to diagnose obstructive CAD because of its low specificity. 1

  • In symptomatic patients with zero calcium score, 7-38% still have obstructive disease, as CAC=0 does not exclude non-calcified plaque or obstructive coronary disease. 2, 3

  • CAC scoring should be seen primarily as a marker of atherosclerosis and not of degree of stenosis. 3, 5

  • Coronary calcifications are not an indicator of stability or instability of an atherosclerotic plaque. 5

Inappropriate Uses

  • Screening asymptomatic patients using coronary CT angiography (as opposed to calcium scoring alone) is considered inappropriate. 2

  • Repeat coronary calcium testing is considered inappropriate. 2

  • CAC scoring is generally not recommended for men <40 years or women <50 years due to low prevalence of detectable calcium and radiation exposure concerns. 2

  • Low-risk patients (<6% 10-year risk) without a family history of premature coronary heart disease should not undergo CAC measurement. 2

Age and Sex Considerations

  • The prevalence and severity of CAC is strongly related to increasing age and sex, with women having less prevalent and less severe CAC than men. 1

  • For women, the prevalence of CAC is low premenopausally, and across age deciles, prevalence lags by 10 years when compared with male counterparts. 1

  • These distributions have been developed largely in white women and should not be applied to nonwhite women until ethnicity-specific data are developed. 1

Emerging Applications

  • Opportunistic detection of CAC on non-ECG-gated chest CT scans performed for noncardiac indications can enhance atherosclerotic cardiovascular disease risk stratification without additional radiation exposure, cost, or burden. 7

  • Approximately 19 million non-ECG-gated chest CT scans are performed per year, and reporting opportunistic CAC from these scans has potential to alert physicians of risk independent of guideline-recommended risk calculator use. 7

  • Advancements in artificial intelligence allow integration of automated CAC quantification into clinical practice to improve reporting and appropriate allocation of preventive therapies. 7

References

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.